Quanterix Corporation
General ticker "QTRX" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $268.6M (TTM average)
Quanterix Corporation follows the US Stock Market performance with the rate: 8.8%.
Estimated limits based on current volatility of 4.8%: low 6.97$, high 7.67$
Factors to consider:
- Total employees count: 471 as of 2024
- North America accounted for 2.9% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Acquisition/divestiture risks, Operational and conduct risks, Operating losses, Market acceptance, Dependence on key customers
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [4.74$, 12.36$]
- 2025-12-31 to 2026-12-31 estimated range: [3.94$, 10.17$]
Financial Metrics affecting the QTRX estimates:
- Negative: with PPE of -10.3 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -8.62 <= 0.33
- Positive: Shareholder equity ratio, % of 81.18 > 63.39
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
- Negative: Industry earnings per price (median), % of -3.67 <= 0
Short-term QTRX quotes
Long-term QTRX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $105.52MM | $122.37MM | $137.42MM |
| Operating Expenses | $207.23MM | $172.07MM | $190.04MM |
| Operating Income | $-101.70MM | $-49.70MM | $-52.62MM |
| Non-Operating Income | $5.07MM | $18.09MM | $14.52MM |
| R&D Expense | $25.89MM | $24.86MM | $31.08MM |
| Income(Loss) | $-96.64MM | $-31.61MM | $-38.10MM |
| Taxes | $0.07MM | $0.72MM | $0.43MM |
| Profit(Loss)* | $-96.70MM | $-32.33MM | $-38.53MM |
| Stockholders Equity | $358.94MM | $346.93MM | $330.04MM |
| Inventory | $16.96MM | $26.12MM | $32.77MM |
| Assets | $434.20MM | $425.01MM | $406.53MM |
| Operating Cash Flow | $-48.27MM | $-18.90MM | $-35.16MM |
| Capital expenditure | $11.73MM | $3.79MM | $3.37MM |
| Investing Cash Flow | $-11.21MM | $-148.40MM | $-82.27MM |
| Financing Cash Flow | $2.31MM | $2.69MM | $0.46MM |
| Earnings Per Share** | $-2.61 | $-0.86 | $-1.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.